Latest News

Monday, March 27, 2017 | Health Care

US Lawmakers Pull Bill Intended to Repeal Affordable Healthcare Act

On Friday, Republican lawmakers in the US House of Representatives withdrew proposed legislation aimed at overhauling the Affordable Healthcare Act, signed into law by fo…

Read the full story

Monday, March 27, 2017 | Medical Studies

Many Youths Not Adequately Screened for Diabetic Retinopathy

Many youths with diabetes did not receive timely eye examinations to screen for diabetic retinopathy (DR), a new study shows. Sophia Y. Wang, MD, from the University of Michigan Medical School, Ann Ar…

Read the full story

Friday, March 24, 2017 | Product Releases

Aptar Pharma's Preservative-Free Multidose Dispenser Chosen for the First Time for a Prescription Dry Eye Product in the US with Restasis Multidose

Aptar Pharma’s innovative and patented preservative-free multidose ophthalmic squeeze dispenser is available for patients in the US prescription market for the first time with Allergan’s&n…

Read the full story

Friday, March 24, 2017 | Medical Studies

How Blind People's Brains Rewire to Improve Other Senses

A new study delves into the neurological changes in people with blindness. It demonstrates that losing one's sight before the age of 3 causes long-term alterations and subsequent enhancements to t…

Read the full story

Friday, March 24, 2017 | Medical Studies

Repeated Bevacizumab Injections Tied to Higher Glaucoma Surgery Risk

Seven or more intravitreous bevacizumab injections in a year is associated with a higher risk of glaucoma surgery, researchers in Canada say. "The advent of intravitreous anti-vascular endothelia…

Read the full story

Thursday, March 23, 2017 | FDA Approval/Clearance

Icare USA Receives FDA Clearance for Icare HOME Tonometer

Icare USA announced that the Icare HOME tonometer has been cleared by the FDA and is now available for use in the United States. The Icare HOME device, which received CE marking in 2014, allows eye ca…

Read the full story

Thursday, March 23, 2017 | Conferences, Ellex

Ellex to Broadcast ABiC Surgery Event Live From Dean McGee Eye Institute

Ellex Medical will host a live online broadcast of its minimally invasive glaucoma surgery (MIGS) procedure ABiC (ab interno canaloplasty) on Tuesday, March 28, 2017 at the Dean McGee Eye Institute, U…

Read the full story

Thursday, March 23, 2017 | Medical Studies

Optical Coherence Tomographic Angiography Helps Track Diabetic Retinopathy

Vessel density as measured by optical coherence tomographic angiography (OCTA) correlates with the severity of diabetic retinopathy (DR) and may yield insight beyond that provided by fundus photograph…

Read the full story

Thursday, March 23, 2017 | FDA Approval/Clearance, Alcon Laboratories

Alcon Receives FDA Approval for AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL with Activefocus

Alcon has received approval from the FDA for its AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL with Activefocus, which is designed to address astigmatism and presbyopia at the same time. The unique opti…

Read the full story

Wednesday, March 22, 2017 | Management/Leadership, Shire

Joe Boyd Joins Shire as Director, Market Development, Ophthalmics

Shire has announced that Joe Boyd has joined the Ophthalmics team as Director, Market Development. In this role, Mr. Boyd will work closely with thought leaders, key opinion leaders, and teaching inst…

Read the full story

Wednesday, March 22, 2017 | Product Releases, Allergan

Allergan Announces Availability of Restasis Multidose (Cyclosporine Ophthalmic Emulsion) 0.05%

Allergan announced the availability of Restasis Multidose, the first and only FDA-approved preservative-free, prescription eye drop in the United States to be available in a multidose bottle. Previous…

Read the full story

Wednesday, March 22, 2017 | Glaucoma,Partnerships, Ora

AXIM Biotech Retains ORA to Manage Glaucoma & Dry Eye Indications Product Development and Clinical Trials

Axim Biotechnologies is retaining the services from contract research organization Ora to run the company’s upcoming product development and clinical trials for the treatment of glaucoma and dry…

Read the full story

Wednesday, March 22, 2017 | Medical Studies, Ocular Therapeutix

New Publication Describes Positive Patient Experience in Study of Ocular Therapeutix’ Dextenza Following Cataract Surgery

Ocular Therapeutix announced positive results of a patient experience study of Dextenza (dexamethasone insert) 0.4 mg for intracanalicular use. The study, published in Patient Preference and Adhe…

Read the full story

Wednesday, March 22, 2017 | Miscellaneous, Prevent Blindness

April Declared Women’s Eye Health and Safety Awareness Month

More women than men have eye disease, including age-related macular degeneration (AMD), cataracts, and glaucoma. According to the Prevent Blindness study, "The Future of Vision: Forecasting the P…

Read the full story

Wednesday, March 22, 2017 | Glaucoma,Medical Studies

Body-tilt Test Helps Predict Optic Nerve Tissue Loss in Glaucoma

Changes in pattern electroretinogram (PERG) and other measures associated with head-down-body-tilt (HDT) position predict future loss of optic nerve tissue in individuals at risk for glaucoma, accordi…

Read the full story
Load More
 Stock Price  Change 
 ADVM $2.80  0.00% 
 Aerie Pharmaceuticals, Inc. $45.25  0.00% 
 Akorn, Inc. $24.46  0.00% 
 Alimera Sciences, Inc. $1.45  0.00% 
 Allergan $241.34  0.00% 
 Applied Genetic Technologies $6.65  0.00% 
 Bayer $115.25  0.00% 
 Can-Fite Biopharma $1.91  0.00% 
 Clearside Biomedical $7.89  0.00% 
 Cooper Companies, Inc. $199.33  0.00% 
 Eleven Biotherapeutics $2.14  0.00% 
 Escalon Medical Corp. $0.09  0.00% 
 Glaukos $50.24  0.00% 
 Imprimis Pharmaceuticals, Inc. $3.99  0.00% 
 Inotek Pharmaceuticals $1.95  0.00% 
 IRIDEX Corporation $12.25  0.00% 
 Johnson & Johnson $124.92  0.00% 
 Luxottica Group, S.p.A. $55.39  0.00% 
 Merck & Company, Inc. $63.64  0.00% 
 NovaBay Pharmaceuticals, Inc. $0.74  0.00% 
 Novartis AG Common Stock $74.85  0.00% 
 Ocular Therapeutix $9.39  0.00% 
 Ophthotech Corporation $3.65  0.00% 
 Regeneron $394.14  0.00% 
 Roche $32.14  0.00% 
 Second Sight Medical Products $1.29  0.00% 
 Shire $178.19  0.00% 
 STAAR Surgical Company $9.75  0.00% 
 TearLab Corporation $3.18  0.00% 
 Valeant Pharmaceuticals $11.18  0.00% 
 Xoma $6.94  0.00%